Dual Protein Inhibition Reverses Lung Scarring in Preclinical Study
In a groundbreaking development poised to transform the therapeutic landscape for idiopathic pulmonary fibrosis (IPF), researchers at Virginia Tech’s Fralin ...
In a groundbreaking development poised to transform the therapeutic landscape for idiopathic pulmonary fibrosis (IPF), researchers at Virginia Tech’s Fralin ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine